NUTEK OIDO · raw details

NUTEK takes part in the fight against cancer by pioneering precision in Surgical Oncology. NUTEK is addressing the problem of cancer tissues that remain undetected on the patient's body after surgical intervention, which is the main cause of subsequent cancer recurrence, repeated operations, and aggressive treatments. Furthermore, the resulting economic burden on hospitals, healthcare organizations insurance companies is significantly high.

NUTEK provides a unique intraoperative solution, the "Rainbow Probe". A high-resolution hyperspectral imaging handheld device, by which surgeons will scan the operation cavity on-the-patient’s-body during surgery. The probe guides the surgeon prior to closing, to the exact location of remaining cancer tissue, which otherwise could remain undetected, for immediate removal.

Its first application is Breast Cancer, for which the NOAM Rainbow Probe is developed, to be followed with addressing high-precision and minimally invasive, cancer surgical interventions. .

NUTEK won first prize at Paul Merage Institute startup competition and received a major non-dilutive grant from the FFG (Austrian Innovation Authority) for a two years project. NUTEK is collaborating with the Medical University of Graz in Austria and with Assuta Ashdod Hospital in Israel, completed pre-clinical experiment on breast cancer, developed MVP (TRL6) and designed critical parts of the end-product.